MedTrace Logo

Risk of Shopping Behavior of Tapentadol Immediate-Release (IR) Compared to Oxycodone Immediate-Release (IR)

NCT01545778 · Status: COMPLETED · Type: OBSERVATIONAL · Enrollment: 646620

Last updated 2012-10-29

No results posted yet for this study

Summary

The purpose of this study is to compare the risk of shopping behavior of tapentadol immediate release with the risk of shopping behavior of oxycodone immediate release.

Conditions

  • Substance Abuse Detection

Interventions

DRUG

Tapentadol IR

Opioid naive patients exposed to tapentadol IR from July 2009 to December 2010.

DRUG

Oxycodone IR

Opioid naive patients exposed to Oxycodone IR from July 2009 to December 2010.

Sponsors & Collaborators

  • Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

    lead INDUSTRY

Principal Investigators

  • Johnson & Johnson Pharmaceutical Research & Development, L.L.C. Clinical Trial · Johnson & Johnson Pharmaceutical Research & Development, L.L.C.

Eligibility

Min Age
18 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2010-02-28
Primary Completion
2012-02-29
Completion
2012-02-29

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT01545778 on ClinicalTrials.gov